glp-1 semaglutide and tirzepatide Troubling Findings in Study of Compounders Difference Between GLP-1, GLP-2, and

Jump to section At a glance Extent of Occurrence (resident/breeding) Extent of Occurrence (non-breeding) Migratory status Breeding endemic IBAs/KBAs identified for this species IUCN Red List assessment IUCN Red List category Criteria: Justification for Red List category Distribution Range Extent of Occurrence (resident/breeding) Extent of Occurrence (non-breeding) Continuing decline in EOO Area of Occupancy (AOO) Continuing decline in AOO Breeding endemic Range description Number of locations Continuing decline in number of locations Severely fragmented Very restricted AOO/number of locations Country/territory distribution Population Number of mature individuals Year of estimate Data quality Derivation Number of subpopulations All individuals in one subpopulation Current population trend Continuing decline in mature individuals Extreme fluctuations in mature individuals Extreme fluctuations in subpopulations Continuing decline in number of subpopulations Trend justification Ecology Habitat and ecology Ecosystems Migratory status Elevation Occasional elevation limits Generation length Species type Forest dependency Habitat classification Threats Threats impacting the species Threat classification Use and trade Use and trade summary End uses Conservation action Conservation actions underway and needed Conservation actions in place Alliance for Zero Extinction species Search for Lost Birds species Conservation actions needed Research needed Assessment history IUCN Red List assessment history Note that a change in IUCN Red List category does not necessarily indicate a genuine change in the status of the species, but may simply reflect improved knowledge of the species' status

FOR MAINTAIN A HEALTHY WEIGHT SOURCE: National Institute on Aging

Participants with baseline body mass indexes above 30 saw the most substantial improvements in both weight and metabolic markers

Subgroup analyses showed no difference in adverse event rates or weight loss efficacy between supplement users and non-users

Retatrutide is not approved for consumer use or therapeutic application

See our dedicated Retatrutide Thailand page for domestic supply details